Evidence map›Paper›PMID 26881022›Full record

ArticleOxidative medicine and cellular longevity2016

Evidence for Detrimental Cross Interactions between Reactive Oxygen and Nitrogen Species in Leber's Hereditary Optic Neuropathy Cells.

Micol Falabella, Elena Forte, Maria Chiara Magnifico, Paolo Santini, Marzia Arese, Alessandro Giuffrè, Kristina Radić, Luciana Chessa, Giulia Coarelli, Maria Chiara Buscarinu and 3 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Maculopapillary Bundle Degeneration in Optic Neuropathies.Current neurology and neuroscience reports · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Micol FalabellaDepartment of Biochemical Sciences and Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy.ORCID 0000-0002-1020-1848
Elena ForteDepartment of Biochemical Sciences and Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy.ORCID 0000-0001-9049-6916
Maria Chiara MagnificoDepartment of Biochemical Sciences and Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy.ORCID 0000-0002-0443-2674
Paolo SantiniDepartment of Biochemical Sciences and Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy.
Marzia AreseDepartment of Biochemical Sciences and Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy.ORCID 0000-0002-6140-2287
Alessandro GiuffrèCNR Institute of Molecular Biology and Pathology, 00185 Rome, Italy.ORCID 0000-0001-5301-0681
Kristina RadićFaculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia.ORCID 0000-0001-5792-5061
Luciana ChessaDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-2083-8655
Giulia CoarelliCentre for Experimental Neurological Therapies, S. Andrea Hospital-Site, Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-7824-8343
Maria Chiara BuscarinuCentre for Experimental Neurological Therapies, S. Andrea Hospital-Site, Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-4839-1528
Rosella MechelliCentre for Experimental Neurological Therapies, S. Andrea Hospital-Site, Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0001-5842-3100
Marco SalvettiCentre for Experimental Neurological Therapies, S. Andrea Hospital-Site, Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-0501-8803
Paolo SartiDepartment of Biochemical Sciences and Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy.ORCID 0000-0002-8219-4827
Istituto Pasteur · ITAzienda Ospedaliera Sant'Andrea · ITInstitute of Molecular Biology and Pathology · ITSapienza University of Rome · ITUniversity of Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here we have collected evidence suggesting that chronic changes in the NO homeostasis and the rise of reactive oxygen species bioavailability can contribute to cell dysfunction in Leber's hereditary optic neuropathy (LHON) patients. We report that peripheral blood mononuclear cells (PBMCs), derived from a female LHON patient with bilateral reduced vision and carrying the pathogenic mutation 11778/ND4, display increased levels of reactive oxygen species (ROS) and reactive nitrogen species (RNS), as revealed by flow cytometry, fluorometric measurements of nitrite/nitrate, and 3-nitrotyrosine immunodetection. Moreover, viability assays with the tetrazolium dye MTT showed that lymphoblasts from the same patient are more sensitive to prolonged NO exposure, leading to cell death. Taken together these findings suggest that oxidative and nitrosative stress cooperatively play an important role in driving LHON pathology when excess NO remains available over time in the cell environment.

Indexed as

Adenosine TriphosphateAdultCell SurvivalFemaleFlow CytometryFluorometryHumansLeukocytes, MononuclearLymphocytesMutationNitritesNitrogenOptic Atrophy, Hereditary, LeberOxidative StressOxygenOxygen Consumption3-nitrotyrosineAdenosine TriphosphateNitritesNitrogenOxygenReactive Nitrogen SpeciesReactive Oxygen SpeciesTyrosine

Identifiers

PMID26881022
PMCPMC4736215
OpenAlexW2218209470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.